Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0134 | 0.2618 | 0.5 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0134 | 0.2618 | 0.0678 |
Entamoeba histolytica | bromodomain-containing protein | 0.0097 | 0.1513 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0134 | 0.2618 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0376 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.2618 | 0.2618 |
Onchocerca volvulus | Ubiquitin thioesterase ZRANB1 homolog | 0.0134 | 0.2618 | 0.1302 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.0134 | 0.2618 | 0.17 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0376 | 1 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0376 | 1 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0135 | 0.2661 | 0.1353 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Echinococcus granulosus | CREB binding protein | 0.0116 | 0.2082 | 0.1306 |
Schistosoma mansoni | brg-1 associated factor | 0.0376 | 1 | 1 |
Echinococcus multilocularis | Bromodomain containing protein | 0.0097 | 0.1513 | 0.0457 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0134 | 0.2618 | 0.1776 |
Onchocerca volvulus | 0.0134 | 0.2618 | 0.1302 | |
Schistosoma mansoni | fusion | 0.0134 | 0.2618 | 0.0678 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0376 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0217 | 0.5142 | 0.4588 |
Schistosoma mansoni | hypothetical protein | 0.0376 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Onchocerca volvulus | 0.0376 | 1 | 1 | |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.0134 | 0.2618 | 0.1895 |
Leishmania major | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.0134 | 0.2618 | 0.17 |
Giardia lamblia | Kinase, putative | 0.0097 | 0.1513 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0134 | 0.2618 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0376 | 1 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0376 | 1 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0134 | 0.2618 | 0.0678 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0134 | 0.2618 | 0.1776 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.2618 | 0.2618 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0134 | 0.2618 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0376 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0376 | 1 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0134 | 0.2618 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Schistosoma mansoni | RNA binding protein | 0.0134 | 0.2618 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.5142 | 0.5142 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0217 | 0.5142 | 0.4276 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.0134 | 0.2618 | 0.17 |
Toxoplasma gondii | Zn-finger in Ran binding protein and others domain-containing protein | 0.0134 | 0.2618 | 0.1302 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0134 | 0.2618 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0376 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0134 | 0.2618 | 0.1776 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0134 | 0.2618 | 0.5 |
Onchocerca volvulus | 0.0134 | 0.2618 | 0.1302 | |
Toxoplasma gondii | ran binding protein | 0.0134 | 0.2618 | 0.1302 |
Brugia malayi | TAZ zinc finger family protein | 0.0116 | 0.2082 | 0.1178 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0217 | 0.5142 | 0.4276 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0135 | 0.2661 | 0.1353 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0134 | 0.2618 | 0.5 |
Trichomonas vaginalis | bromodomain containing protein, putative | 0.0135 | 0.2661 | 0.1353 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0097 | 0.1513 | 0.1513 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0376 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0376 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.2618 | 0.2618 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.2618 | 0.2618 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0135 | 0.2661 | 0.1353 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0376 | 1 | 1 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0135 | 0.2661 | 0.1353 |
Schistosoma mansoni | hypothetical protein | 0.0134 | 0.2618 | 0.0678 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.0134 | 0.2618 | 0.17 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0376 | 1 | 1 |
Onchocerca volvulus | 0.0134 | 0.2618 | 0.1302 | |
Entamoeba histolytica | bromodomain-containing protein | 0.0097 | 0.1513 | 0.5 |
Echinococcus multilocularis | bromodomain containing 2 | 0.0217 | 0.5142 | 0.4538 |
Echinococcus granulosus | bromodomain containing 2 | 0.0217 | 0.5142 | 0.4666 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0376 | 1 | 1 |
Echinococcus granulosus | ring and YY1 binding protein | 0.0134 | 0.2618 | 0.1895 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0376 | 1 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0376 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0376 | 1 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.0134 | 0.2618 | 0.1776 |
Onchocerca volvulus | 0.0134 | 0.2618 | 0.1302 | |
Entamoeba histolytica | bromodomain-containing protein | 0.0097 | 0.1513 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0119 | 0.2172 | 0.0776 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0376 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.2618 | 0.2618 |
Loa Loa (eye worm) | CBP-B | 0.0085 | 0.1133 | 0.1133 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0134 | 0.2618 | 0.1776 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.0134 | 0.2618 | 0.1895 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0134 | 0.2618 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0376 | 1 | 1 |
Schistosoma mansoni | bromodomain-containing protein 3 brd3 | 0.0217 | 0.5142 | 0.3865 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0376 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0376 | 1 | 1 |
Echinococcus granulosus | zinc finger protein Ran binding | 0.0134 | 0.2618 | 0.1895 |
Leishmania major | hypothetical protein, conserved | 0.0134 | 0.2618 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0217 | 0.5142 | 0.4588 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.176 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.113 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.027 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.93 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.686 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.559 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.514 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.49 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.418 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.